NVDA
NVIDIA
-- 121.662 TSLA
Tesla
-- 249.870 INTC
Intel
-- 24.055 PLTR
Palantir
-- 86.440 QBTS
D-Wave Quantum
-- 10.140 
NEWS
The FDA Has Granted Fast Track Designation To PureTech Health's LYT-200 For Acute Myeloid Leukemia
Benzinga· 04:081min
Puretech Health(PRTC.US)
Single agent and combination data from Phase 1b AML/MDS trial presented at ASH 2024 showed potential of LYT-200 to serve broad range of patients across various lines of treatmentLYT-200 is currently being evaluated in two Phase 1/2 trials for the potential treatment of AML/MDS and head and neck cancers
Benzinga· 04:081min
Puretech Health(PRTC.US)
Single agent and combination data from Phase 1b AML/MDS trial presented at ASH 2024 showed potential of LYT-200 to serve broad range of patients across various lines of treatmentLYT-200 is currently being evaluated in two Phase 1/2 trials for the potential treatment of AML/MDS and head and neck cancers
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment